EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 168 filers reported holding EAGLE PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $3,359,000 | +4.3% | 72,136 | -4.9% | 0.02% | -53.5% |
| Q3 2020 | $3,222,000 | +33.5% | 75,836 | +50.8% | 0.04% | +126.3% |
| Q2 2020 | $2,413,000 | -99.9% | 50,296 | -2.3% | 0.02% | -17.4% |
| Q1 2020 | $2,369,000,000 | -30.8% | 51,496 | -9.6% | 0.02% | 0.0% |
| Q4 2019 | $3,424,000,000 | +102661.1% | 56,996 | -3.2% | 0.02% | 0.0% |
| Q3 2019 | $3,332,000 | +0.8% | 58,896 | -0.8% | 0.02% | 0.0% |
| Q2 2019 | $3,307,000 | +22.4% | 59,396 | +11.0% | 0.02% | +21.1% |
| Q1 2019 | $2,701,000 | +26.0% | 53,496 | +0.6% | 0.02% | +5.6% |
| Q4 2018 | $2,143,000 | -27.3% | 53,196 | +25.2% | 0.02% | -14.3% |
| Q3 2018 | $2,946,000 | – | 42,496 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 113,737 | $3,227 | 0.98% |
| Smith, Graham & Co., Investment Advisors, LP | 236,883 | $6,720,371 | 0.82% |
| Capital Impact Advisors, LLC | 13,607 | $386,031 | 0.47% |
| TANG CAPITAL MANAGEMENT LLC | 80,000 | $2,269,600 | 0.34% |
| BRANDES INVESTMENT PARTNERS, LP | 545,050 | $15,463,069 | 0.33% |
| Watershed Asset Management, L.L.C. | 9,496 | $269,402 | 0.33% |
| Jackson Creek Investment Advisors LLC | 25,164 | $714 | 0.30% |
| SummerHaven Investment Management, LLC | 18,178 | $515,710 | 0.30% |
| Virtus Fund Advisers, LLC | 1,117 | $31,689 | 0.22% |
| Virtus Investment Advisers, Inc. | 7,308 | $207,328 | 0.14% |